18/06/26

Join the 2026 edition of our annual Johnson & Johnson R&D Symposium, themed “Virtual Biology: From Cells to Patients – Transforming Data into Translational Insights and Patient Impact.” The event will take place on Thursday, June 18, 2026, at the J&J campus in Beerse, Belgium.

This year’s program will dive into the evolving field of Virtual Biology, exploring breakthroughs from the cell, organ, and patient perspectives. We will showcase how multi‑scale biological data and advanced computational approaches are driving actionable (pre)clinical insights, accelerating clinical research, and improving outcomes for patients.

Speakers include Sylvia Boj (Chief Scientific Officer at HUB Organoids), Mar Cóndor (Principal Member of Technical staff at imec), Stanley Durrleman (CEO & co-founder of Qairnel), Jos Joore (CEO Mimetas), Steven Niederer (Chair of Biochemical Engineering, Imperial College London), Ketan Patel (Head of Products at Bioptimus), Evangelia Petsalaki (Computational and systems biologist and Group Leader at EMBL‑EBI), Justin Scheer (Vice President In Silico Discovery at Johnson & Johnson), Piet van der Graaf (Head of Quantitative Systems Pharmacology at Certara) and others.

When: Thursday, June 18, 2026, from 9.30 AM to 5 PM

Where: Johnson & Johnson, Turnhoutseweg 30, 2340 Beerse, Belgium

For whom? Researchers, clinicians, and industry leaders

Please register here.

door Idalia Dlugosz